A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.
Tatiana ShaurovaLingyue YanYafei SuLaurie James RichVui King Vincent-ChongHannah CalkinsSaraswati PokharelMartin PetkovichMukund SeshadriYun WuPamela Anne HershbergerPublished in: Cancer communications (London, England) (2023)